GENinCode Plc (LON:GENI – Get Free Report) fell 9.7% on Thursday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 19,180 shares were traded during trading, a decline of 97% from the average session volume of 598,022 shares. The stock had previously closed at GBX 1.55 ($0.02).
GENinCode Stock Down 9.7%
The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.28. The company has a 50-day moving average of GBX 1.67 and a 200-day moving average of GBX 2.14. The company has a market capitalization of £4.02 million, a price-to-earnings ratio of -55.34 and a beta of 0.66.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- Stock Market Sectors: What Are They and How Many Are There?
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- Airline Stocks – Top Airline Stocks to Buy Now
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- Which Wall Street Analysts are the Most Accurate?
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
